Last edition
Evonik opens German lipid manufacturing plant
Evonik has opened a lipid manufacturing facility in Hanau, Germany. Lipids produced at the plant will be used for RNA drugs and gene therapies aimed at infectious diseases, cancer and more. The facility supports the production of all types of custom and proprietary lipids.
Evonik aims to substantially increase its presence in the life sciences field by 2030. The company has set a goal of investing more than 3 billion euros ($3.16 billion) in next-generation solutions to achieve its goals.
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy